Cue Biopharma, Inc. (CUE)

NCM – Real Time Price. Currency in USD

28.60

+0.36 (1.27%)

Market open: Aug 12, 2026, 3:05 PM EDT

29.82

+1.58 (5.61%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

27M

Cost of goods sold

-348K

-2M

-3M

-2M

Gross Profit

27M

-561K

Operating expenses (excl. COGS)

-54M

-49M

-54M

-53M

Operating Income

-27M

-42M

-52M

-54M

Non-operating income, total

419K

919K

491K

Pretax income

-26M

-41M

-51M

-53M

Equity in earnings

Taxes

-500K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-27M

-41M

-51M

-53M

Discontinued operations

Net income

-27M

-41M

-51M

-53M

Dilution adjustment

Preferred dividends

Cue Biopharma, Inc. (CUE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Cue Biopharma, Inc. (CUE)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Cue Biopharma, Inc. (CUE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Cue Biopharma, Inc. (CUE)

Income Statement (Annual)

Income Statement (Annual)